Building Your Child's Care Team
At a Glance
Children with MLC often benefit from a coordinated team led by a pediatric neurologist, with genetics, rehabilitation, and other specialists added to meet their needs. Bring MRI images, the full genetic report, prior evaluations, school plans, and a symptom timeline to the first visit.
Building a care team for a rare condition like Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is less about finding a single doctor and more about assembling a “neighborhood” of specialists who work together [1]. Because MLC can affect everything from how your child moves to how they eat and learn, you need a team that can manage both the day-to-day symptoms and the long-term journey of a leukodystrophy [2].
The Essential Specialists
An ideal care team for a child with MLC is multidisciplinary, meaning experts from different fields meet to discuss your child’s progress [2]. If you are far from a rare-disease center, local and remote care can often be coordinated.
- Pediatric Neurologist: This is typically the “captain” of your medical team. They monitor brain development, manage seizures, and track motor function over time [3][4].
- Clinical Geneticist and Genetic Counselor: These specialists interpret the complex genetic reports (like MLC1 or HEPACAM variants) and provide genetic counseling for your family [1][4].
- Rehabilitation Team: This includes Physical Therapists (PT), Occupational Therapists (OT), and Speech/Language Pathologists [5]. Early referral to these experts is a “pillar” of MLC care, helping your child stay independent and participate in daily activities [6].
- Pediatric Neuroradiologist: While you may not meet them directly, this expert is crucial for reviewing your child’s MRI scans to look for the specific swelling and cyst patterns that define MLC [7][8].
- Supportive Specialists: Depending on your child’s needs, you may also work with an Orthopedist for bone/joint health, a Gastroenterologist (GI) for feeding concerns, a Pulmonologist for respiratory support, as well as a Developmental Pediatrician, Neuropsychologist, or Social Worker to support comprehensive wellbeing [2].
Vetting Your Care Team
When you meet with a specialist, it is helpful to evaluate how much experience they have with rare white matter disorders. You might ask if the team has evaluated children with both the classic and remitting types of MLC, as the outlook and needs for these children can be very different [8]. A strong center will be able to explain how your child’s specific MRI findings match their genetic results, rather than relying on the lab report alone [7][9].
You should also ask about coordination: Who is the designated “lead” clinician you should call between visits for seizures or sudden changes? Will the center provide a written care plan that you can share with your child’s school and local therapists? [5][1] Reputable leukodystrophy organizations and family-support resources can also be invaluable connections.
What to Bring to the First Visit
For a first appointment at a major leukodystrophy center, arriving prepared helps the team focus on your child rather than paperwork. You should bring copies of the following “artifacts”:
- MRI Images: Ask the receiving center how it accepts “DICOM” images—often through a secure portal or approved physical media [10]. Specialists need to see the actual brain structures, as the written radiology report from another hospital may not contain the level of detail they require [7].
- Genetic Testing Reports: Bring the full, multi-page report from the lab. This contains the exact “address” of the mutation, which is vital for distinguishing between types of MLC [10][11].
- Prior Evaluations: Include records from any previous PT, OT, or speech evaluations, as well as school Individualized Education Programs (IEP) or equivalent school support plans. These help the doctors see how your child is performing in the “real world” [10][5].
- A Growth and Symptom Timeline: A dated list of when your child’s head size was first noticed, when milestones were reached, and when any symptoms (like clumsiness or seizures) began [10].
By bringing these items and asking about experience and coordination, you ensure that your child’s care team is not just treating a diagnosis, but supporting your child’s unique life [12].
Common questions in this guide
Which specialists are usually part of a care team for a child with MLC?
What should I bring to my child’s first MLC specialist visit?
Why are the actual MRI images important for MLC care?
How can doctors tell whether MLC is classic or remitting?
Can a rare-disease center work with our local therapists?
Who should I contact if my child has a new symptom or seizure?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Team experience
Could I ask how much experience your team has with the classic and remitting types of MLC?
Care coordination
Could I ask who the lead clinician is to call between visits for sudden changes?
Sharing medical records
Which MRI images and genetic testing reports should I bring, and how can I send them?
Get notified when new evidence is published on Megalencephalic leukoencephalopathy with subcortical cysts.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Van der Knaap Disease Unveiled: A Radiological-Genomic Journey From Seizure to Diagnosis.
Jaiswal M, Yadav A, Goyal BR, et al.
Cureus 2026; (18(7)):e112696 doi:10.7759/cureus.112696.
PMID: 42602541 - 2
Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.
Sartorelli J, Tonduti D, Ambrosini E, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):66 doi:10.1007/s10072-025-08610-z.
PMID: 41483250 - 3
Seizures and disturbed brain potassium dynamics in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts.
Dubey M, Brouwers E, Hamilton EMC, et al.
Annals of neurology 2018; (83(3)):636-649 doi:10.1002/ana.25190.
PMID: 29466841 - 4
Ten Novel Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts and a Long-Term Follow-Up Research.
Cao B, Yan H, Guo M, et al.
PloS one 2016; (11(6)):e0157258 doi:10.1371/journal.pone.0157258.
PMID: 27322623 - 5
The Gross, Fine, and Oral Motor Functions in a Patient with Megalencephalic Leukoencephalopathy with Subcortical Cyst: A Case Report.
Sabermoghadam R, Maleki Shahmahmood T, Sarvghadi P, Beiraghi Toosi M
Iranian journal of child neurology 2023; (17(2)):149-161 doi:10.22037/ijcn.v17i1.37156.
PMID: 37091475 - 6
Megalencephalic leucoencephalopathy with subcortical cysts: subcortical diffuse leucoencephalopathy associated with white matter cystic degeneration.
Dash PK, Raj DH, Sahu H
BMJ case reports 2015; (2015()).
PMID: 26392452 - 7
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
Ashrafi MR, Amanat M, Garshasbi M, et al.
Expert review of neurotherapeutics 2020; (20(1)):65-84 doi:10.1080/14737175.2020.1699060.
PMID: 31829048 - 8
Megalencephalic leukoencephalopathy with subcortical cysts: Characterization of disease variants.
Hamilton EMC, Tekturk P, Cialdella F, et al.
Neurology 2018; (90(16)):e1395-e1403 doi:10.1212/WNL.0000000000005334.
PMID: 29661901 - 9
Diagnostic Pitfall in Genomic Era: Discordant SMARCA2 Finding in Patient with Megalencephalic Leukoencephalopathy with Subcortical Cysts.
Wang CH, Lin SP, Huang JK, Chiu NC
Diagnostics (Basel, Switzerland) 2026; (16(15)) doi:10.3390/diagnostics16152314.
PMID: 42587552 - 10
Rigorous genetic diagnosis review in natural history studies.
Pizzino A, Arnold K, Wiener E, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42050713 - 11
Megalencephalic leukoencephalopathy with subcortical cysts: a variant update and review of the literature.
Passchier EMJ, Bisseling Q, Helman G, et al.
Frontiers in genetics 2024; (15()):1352947 doi:10.3389/fgene.2024.1352947.
PMID: 38487253 - 12
Patient and Family Perspectives on Clinical Outcomes in Therapy Trials in Megalencephalic Leukoencephalopathy with Subcortical Cysts: An Open Inventory.
Versaevel NRA, Chapleau A, Topaloğlu P, et al.
Neuropediatrics 2026; (57(3)):186-192 doi:10.1055/a-2851-9956.
PMID: 42025183
This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric neurologist or leukodystrophy team can tailor specialist referrals, monitoring, and emergency instructions to your child.